Gecacitinib Hydrochloride Tablets Clinical Trials
3 recruitingDrug
Phase 13Phase 23
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
Study of ZG005 Combined With Gecacitinib in Patients With Advanced Non-Small Cell Lung Cancer
Non-small Cell Lung Cancer
Suzhou Zelgen Biopharmaceuticals Co.,Ltd50 enrolled1 locationNCT06903377
Recruiting
Phase 1Phase 2
Study of ZG005 in Combination With Gecacitinib in Patients With Relapsed or Refractory Lymphoma
Lymphoma
Suzhou Zelgen Biopharmaceuticals Co.,Ltd60 enrolled1 locationNCT06883526
Recruiting
Phase 1Phase 2
Gecacitinib for cGVHD: Safety and Efficacy in Patients After ≥2 Lines of Prior Therapy
Chronic Graft Versus Host Disease
Yujun DONG24 enrolled1 locationNCT07012304